InvestorsHub Logo
Followers 151
Posts 7487
Boards Moderated 0
Alias Born 07/11/2011

Re: None

Monday, 04/13/2020 10:34:56 AM

Monday, April 13, 2020 10:34:56 AM

Post# of 3729
Immunovant announces positive clinical results from ongoing Phase 2a proof-of-concept study of #OmniAb-derived IMVT-1401, a novel investigational anti-FcRn antibody, in Thyroid Eye Disease
https://t.co/NO4rPGPJE5
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LGND News